BMRK-01 EXTERNALLY VALIDATED PREDICTIVE NOMOGRAM FOR BRAIN METASTASIS IN EARLY-STAGE BREAST CANCER Article Swipe

View

Kristofer Jennings , Akshara Singareeka Raghavendra , Nuria Kotecki , Ottavia Amato , Debu Tripathy , Ahmad Awada , Nuhad Ibrahim ·

YOU? · · 2024 · Open Access · · DOI: https://doi.org/10.1093/noajnl/vdae090.024

BACKGROUND Brain metastasis presents a significant concern for early-stage breast cancer (ESBC) patients, impacting their survival and overall well-being. Constructing a predictive nomogram based on primary tumor characteristics offers a way to anticipate the likelihood of brain metastasis. The objective is to create tools aiding in the identification of high-risk patients, enriching clinical trial cohorts to prevent or delay brain metastasis onset early in the disease. METHODS We reviewed 40,290 ESBC cases (stages I-III) at the University of Texas MD Anderson Cancer Center, Houston, spanning January 1, 1997, to May 8, 2020. Validated the model with Institut Jules Bordet, Belgium, patient data for accuracy and reproducibility analyzing 1,644 cases with the same inclusion criteria.Statistical models considered patient age, tumor features (grade, hormone receptor, HER2 status), and treatments (chemotherapy, endocrine therapy). Using these, our multivariate model predicted brain metastasis occurrence over 1, 2, and 5 years, evaluated through Receiver Operating Characteristic (ROC) analysis. RESULTS Key predictors for brain metastasis included younger age, high estrogen and progesterone receptor percentage, higher tumor size; use of aromatase inhibitor therapy, and use of selective estrogen receptor modulator therapy were associated with a decreased risk of brain metastasis. Higher grade, Ki-67 levels, HER2-positive status, lymphovascular invasion and the use of chemotherapy was associated with an increased risk. The AUC values for the prediction of brain metastasis at various time intervals in the test cohort were 0.81 at 4 years, 0.80 at 5 years, and 0.77 at 10 years. In the validation cohort, the AUCs were 0.81 at 4 and 5 years, decreasing to 0.70 at the 10-year mark. CONCLUSIONS This tool offers valuable support to clinicians in personalized patient care decisions regarding brain metastasis risk. Continuous validation and research will enhance these models, bolstering reliability and applicability in clinical and research settings.

Related Topics

Concepts

Nomogram Stage (stratigraphy) Breast cancer Oncology Brain metastasis Medicine Internal medicine Cancer Metastasis Biology Paleontology

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1093/noajnl/vdae090.024
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4401305894

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4401305894

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1093/noajnl/vdae090.024

Digital Object Identifier
Title: BMRK-01 EXTERNALLY VALIDATED PREDICTIVE NOMOGRAM FOR BRAIN METASTASIS IN EARLY-STAGE BREAST CANCER

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2024

Year of publication
Publication date: 2024-08-01

Full publication date if available
Authors: Kristofer Jennings, Akshara Singareeka Raghavendra, Nuria Kotecki, Ottavia Amato, Debu Tripathy, Ahmad Awada, Nuhad Ibrahim

List of authors in order
Landing page: https://doi.org/10.1093/noajnl/vdae090.024

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1093/noajnl/vdae090.024

Direct OA link when available
Concepts: Nomogram, Stage (stratigraphy), Breast cancer, Oncology, Brain metastasis, Medicine, Internal medicine, Cancer, Metastasis, Biology, Paleontology

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4401305894
doi	https://doi.org/10.1093/noajnl/vdae090.024
ids.doi	https://doi.org/10.1093/noajnl/vdae090.024
ids.openalex	https://openalex.org/W4401305894
fwci	0.0
type	article
title	BMRK-01 EXTERNALLY VALIDATED PREDICTIVE NOMOGRAM FOR BRAIN METASTASIS IN EARLY-STAGE BREAST CANCER
biblio.issue	Supplement_1
biblio.volume	6
biblio.last_page	i8
biblio.first_page	i8
topics[0].id	https://openalex.org/T12702
topics[0].field.id	https://openalex.org/fields/28
topics[0].field.display_name	Neuroscience
topics[0].score	0.9495999813079834
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/2808
topics[0].subfield.display_name	Neurology
topics[0].display_name	Brain Tumor Detection and Classification
topics[1].id	https://openalex.org/T11600
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9430000185966492
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2740
topics[1].subfield.display_name	Pulmonary and Respiratory Medicine
topics[1].display_name	Brain Metastases and Treatment
is_xpac	False
apc_list.value	1622
apc_list.currency	GBP
apc_list.value_usd	1989
apc_paid.value	1622
apc_paid.currency	GBP
apc_paid.value_usd	1989
concepts[0].id	https://openalex.org/C34626388
concepts[0].level	2
concepts[0].score	0.9129605293273926
concepts[0].wikidata	https://www.wikidata.org/wiki/Q721129
concepts[0].display_name	Nomogram
concepts[1].id	https://openalex.org/C146357865
concepts[1].level	2
concepts[1].score	0.7575138807296753
concepts[1].wikidata	https://www.wikidata.org/wiki/Q1123245
concepts[1].display_name	Stage (stratigraphy)
concepts[2].id	https://openalex.org/C530470458
concepts[2].level	3
concepts[2].score	0.6722293496131897
concepts[2].wikidata	https://www.wikidata.org/wiki/Q128581
concepts[2].display_name	Breast cancer
concepts[3].id	https://openalex.org/C143998085
concepts[3].level	1
concepts[3].score	0.5893877148628235
concepts[3].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[3].display_name	Oncology
concepts[4].id	https://openalex.org/C2778164965
concepts[4].level	4
concepts[4].score	0.5336877107620239
concepts[4].wikidata	https://www.wikidata.org/wiki/Q1620196
concepts[4].display_name	Brain metastasis
concepts[5].id	https://openalex.org/C71924100
concepts[5].level	0
concepts[5].score	0.5123459100723267
concepts[5].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[5].display_name	Medicine
concepts[6].id	https://openalex.org/C126322002
concepts[6].level	1
concepts[6].score	0.44698405265808105
concepts[6].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[6].display_name	Internal medicine
concepts[7].id	https://openalex.org/C121608353
concepts[7].level	2
concepts[7].score	0.43033555150032043
concepts[7].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[7].display_name	Cancer
concepts[8].id	https://openalex.org/C2779013556
concepts[8].level	3
concepts[8].score	0.39113837480545044
concepts[8].wikidata	https://www.wikidata.org/wiki/Q181876
concepts[8].display_name	Metastasis
concepts[9].id	https://openalex.org/C86803240
concepts[9].level	0
concepts[9].score	0.08951833844184875
concepts[9].wikidata	https://www.wikidata.org/wiki/Q420
concepts[9].display_name	Biology
concepts[10].id	https://openalex.org/C151730666
concepts[10].level	1
concepts[10].score	0.0
concepts[10].wikidata	https://www.wikidata.org/wiki/Q7205
concepts[10].display_name	Paleontology
keywords[0].id	https://openalex.org/keywords/nomogram
keywords[0].score	0.9129605293273926
keywords[0].display_name	Nomogram
keywords[1].id	https://openalex.org/keywords/stage
keywords[1].score	0.7575138807296753
keywords[1].display_name	Stage (stratigraphy)
keywords[2].id	https://openalex.org/keywords/breast-cancer
keywords[2].score	0.6722293496131897
keywords[2].display_name	Breast cancer
keywords[3].id	https://openalex.org/keywords/oncology
keywords[3].score	0.5893877148628235
keywords[3].display_name	Oncology
keywords[4].id	https://openalex.org/keywords/brain-metastasis
keywords[4].score	0.5336877107620239
keywords[4].display_name	Brain metastasis
keywords[5].id	https://openalex.org/keywords/medicine
keywords[5].score	0.5123459100723267
keywords[5].display_name	Medicine
keywords[6].id	https://openalex.org/keywords/internal-medicine
keywords[6].score	0.44698405265808105
keywords[6].display_name	Internal medicine
keywords[7].id	https://openalex.org/keywords/cancer
keywords[7].score	0.43033555150032043
keywords[7].display_name	Cancer
keywords[8].id	https://openalex.org/keywords/metastasis
keywords[8].score	0.39113837480545044
keywords[8].display_name	Metastasis
keywords[9].id	https://openalex.org/keywords/biology
keywords[9].score	0.08951833844184875
keywords[9].display_name	Biology
language	en
locations[0].id	doi:10.1093/noajnl/vdae090.024
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S4210237914
locations[0].source.issn	2632-2498
locations[0].source.type	journal
locations[0].source.is_oa	True
locations[0].source.issn_l	2632-2498
locations[0].source.is_core	True
locations[0].source.is_in_doaj	True
locations[0].source.display_name	Neuro-Oncology Advances
locations[0].source.host_organization	https://openalex.org/P4310311648
locations[0].source.host_organization_name	Oxford University Press
locations[0].source.host_organization_lineage	https://openalex.org/P4310311648
locations[0].license	cc-by-nc
locations[0].pdf_url
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/cc-by-nc
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Neuro-Oncology Advances
locations[0].landing_page_url	https://doi.org/10.1093/noajnl/vdae090.024
locations[1].id	pmh:oai:pubmedcentral.nih.gov:11296867
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S2764455111
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	PubMed Central
locations[1].source.host_organization	https://openalex.org/I1299303238
locations[1].source.host_organization_name	National Institutes of Health
locations[1].source.host_organization_lineage	https://openalex.org/I1299303238
locations[1].license	other-oa
locations[1].pdf_url
locations[1].version	submittedVersion
locations[1].raw_type	Text
locations[1].license_id	https://openalex.org/licenses/other-oa
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name	Neurooncol Adv
locations[1].landing_page_url	https://www.ncbi.nlm.nih.gov/pmc/articles/11296867
indexed_in	crossref, doaj
authorships[0].author.id	https://openalex.org/A5033969355
authorships[0].author.orcid	https://orcid.org/0000-0002-5442-9326
authorships[0].author.display_name	Kristofer Jennings
authorships[0].countries	US
authorships[0].affiliations[0].institution_ids	https://openalex.org/I1343551460
authorships[0].affiliations[0].raw_affiliation_string	The University of Texas MD Anderson Cancer Center , Houston/TX, USA
authorships[0].institutions[0].id	https://openalex.org/I1343551460
authorships[0].institutions[0].ror	https://ror.org/04twxam07
authorships[0].institutions[0].type	healthcare
authorships[0].institutions[0].lineage	https://openalex.org/I1343551460
authorships[0].institutions[0].country_code	US
authorships[0].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[0].author_position	first
authorships[0].raw_author_name	Kristofer Jennings
authorships[0].is_corresponding	False
authorships[0].raw_affiliation_strings	The University of Texas MD Anderson Cancer Center , Houston/TX, USA
authorships[1].author.id	https://openalex.org/A5016698215
authorships[1].author.orcid	https://orcid.org/0000-0002-6425-4400
authorships[1].author.display_name	Akshara Singareeka Raghavendra
authorships[1].countries	US
authorships[1].affiliations[0].institution_ids	https://openalex.org/I1343551460
authorships[1].affiliations[0].raw_affiliation_string	The University of Texas MD Anderson Cancer Center , Houston/TX, USA
authorships[1].institutions[0].id	https://openalex.org/I1343551460
authorships[1].institutions[0].ror	https://ror.org/04twxam07
authorships[1].institutions[0].type	healthcare
authorships[1].institutions[0].lineage	https://openalex.org/I1343551460
authorships[1].institutions[0].country_code	US
authorships[1].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[1].author_position	middle
authorships[1].raw_author_name	Akshara Singareeka Raghavendra
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	The University of Texas MD Anderson Cancer Center , Houston/TX, USA
authorships[2].author.id	https://openalex.org/A5030523847
authorships[2].author.orcid	https://orcid.org/0000-0002-7753-230X
authorships[2].author.display_name	Nuria Kotecki
authorships[2].countries	BE
authorships[2].affiliations[0].institution_ids	https://openalex.org/I2801838318
authorships[2].affiliations[0].raw_affiliation_string	Jules Bordet Cancer Institute , Brussels, Belgium
authorships[2].institutions[0].id	https://openalex.org/I2801838318
authorships[2].institutions[0].ror	https://ror.org/05e8s8534
authorships[2].institutions[0].type	healthcare
authorships[2].institutions[0].lineage	https://openalex.org/I2801838318
authorships[2].institutions[0].country_code	BE
authorships[2].institutions[0].display_name	Institut Jules Bordet
authorships[2].author_position	middle
authorships[2].raw_author_name	Nuria Kotecki
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Jules Bordet Cancer Institute , Brussels, Belgium
authorships[3].author.id	https://openalex.org/A5075407319
authorships[3].author.orcid	https://orcid.org/0000-0002-3690-8542
authorships[3].author.display_name	Ottavia Amato
authorships[3].countries	BE
authorships[3].affiliations[0].institution_ids	https://openalex.org/I2801838318
authorships[3].affiliations[0].raw_affiliation_string	Jules Bordet Cancer Institute , Brussels, Belgium
authorships[3].institutions[0].id	https://openalex.org/I2801838318
authorships[3].institutions[0].ror	https://ror.org/05e8s8534
authorships[3].institutions[0].type	healthcare
authorships[3].institutions[0].lineage	https://openalex.org/I2801838318
authorships[3].institutions[0].country_code	BE
authorships[3].institutions[0].display_name	Institut Jules Bordet
authorships[3].author_position	middle
authorships[3].raw_author_name	Ottavia Amato
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Jules Bordet Cancer Institute , Brussels, Belgium
authorships[4].author.id	https://openalex.org/A5110083321
authorships[4].author.orcid
authorships[4].author.display_name	Debu Tripathy
authorships[4].countries	US
authorships[4].affiliations[0].institution_ids	https://openalex.org/I1343551460
authorships[4].affiliations[0].raw_affiliation_string	The University of Texas MD Anderson Cancer Center , Houston/TX, USA
authorships[4].institutions[0].id	https://openalex.org/I1343551460
authorships[4].institutions[0].ror	https://ror.org/04twxam07
authorships[4].institutions[0].type	healthcare
authorships[4].institutions[0].lineage	https://openalex.org/I1343551460
authorships[4].institutions[0].country_code	US
authorships[4].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[4].author_position	middle
authorships[4].raw_author_name	Debu Tripathy
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	The University of Texas MD Anderson Cancer Center , Houston/TX, USA
authorships[5].author.id	https://openalex.org/A5010064853
authorships[5].author.orcid
authorships[5].author.display_name	Ahmad Awada
authorships[5].countries	BE
authorships[5].affiliations[0].institution_ids	https://openalex.org/I2801838318
authorships[5].affiliations[0].raw_affiliation_string	Jules Bordet Cancer Institute , Brussels, Belgium
authorships[5].institutions[0].id	https://openalex.org/I2801838318
authorships[5].institutions[0].ror	https://ror.org/05e8s8534
authorships[5].institutions[0].type	healthcare
authorships[5].institutions[0].lineage	https://openalex.org/I2801838318
authorships[5].institutions[0].country_code	BE
authorships[5].institutions[0].display_name	Institut Jules Bordet
authorships[5].author_position	middle
authorships[5].raw_author_name	Ahmad Awada
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	Jules Bordet Cancer Institute , Brussels, Belgium
authorships[6].author.id	https://openalex.org/A5102658746
authorships[6].author.orcid
authorships[6].author.display_name	Nuhad Ibrahim
authorships[6].countries	US
authorships[6].affiliations[0].institution_ids	https://openalex.org/I1343551460
authorships[6].affiliations[0].raw_affiliation_string	The University of Texas MD Anderson Cancer Center , Houston/TX, USA
authorships[6].institutions[0].id	https://openalex.org/I1343551460
authorships[6].institutions[0].ror	https://ror.org/04twxam07
authorships[6].institutions[0].type	healthcare
authorships[6].institutions[0].lineage	https://openalex.org/I1343551460
authorships[6].institutions[0].country_code	US
authorships[6].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[6].author_position	last
authorships[6].raw_author_name	Nuhad Ibrahim
authorships[6].is_corresponding	False
authorships[6].raw_affiliation_strings	The University of Texas MD Anderson Cancer Center , Houston/TX, USA
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1093/noajnl/vdae090.024
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	BMRK-01 EXTERNALLY VALIDATED PREDICTIVE NOMOGRAM FOR BRAIN METASTASIS IN EARLY-STAGE BREAST CANCER
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T12702
primary_topic.field.id	https://openalex.org/fields/28
primary_topic.field.display_name	Neuroscience
primary_topic.score	0.9495999813079834
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2808
primary_topic.subfield.display_name	Neurology
primary_topic.display_name	Brain Tumor Detection and Classification
related_works	https://openalex.org/W4391375266, https://openalex.org/W2911441101, https://openalex.org/W1970018641, https://openalex.org/W4226494765, https://openalex.org/W1993821226, https://openalex.org/W2063908487, https://openalex.org/W3014240535, https://openalex.org/W2004029742, https://openalex.org/W4233588653, https://openalex.org/W1999313618
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1093/noajnl/vdae090.024
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S4210237914
best_oa_location.source.issn	2632-2498
best_oa_location.source.type	journal
best_oa_location.source.is_oa	True
best_oa_location.source.issn_l	2632-2498
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	True
best_oa_location.source.display_name	Neuro-Oncology Advances
best_oa_location.source.host_organization	https://openalex.org/P4310311648
best_oa_location.source.host_organization_name	Oxford University Press
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310311648
best_oa_location.license	cc-by-nc
best_oa_location.pdf_url
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/cc-by-nc
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Neuro-Oncology Advances
best_oa_location.landing_page_url	https://doi.org/10.1093/noajnl/vdae090.024
primary_location.id	doi:10.1093/noajnl/vdae090.024
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S4210237914
primary_location.source.issn	2632-2498
primary_location.source.type	journal
primary_location.source.is_oa	True
primary_location.source.issn_l	2632-2498
primary_location.source.is_core	True
primary_location.source.is_in_doaj	True
primary_location.source.display_name	Neuro-Oncology Advances
primary_location.source.host_organization	https://openalex.org/P4310311648
primary_location.source.host_organization_name	Oxford University Press
primary_location.source.host_organization_lineage	https://openalex.org/P4310311648
primary_location.license	cc-by-nc
primary_location.pdf_url
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/cc-by-nc
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Neuro-Oncology Advances
primary_location.landing_page_url	https://doi.org/10.1093/noajnl/vdae090.024
publication_date	2024-08-01
publication_year	2024
referenced_works_count	0
abstract_inverted_index.4	232, 252
abstract_inverted_index.5	144, 236, 254
abstract_inverted_index.a	5, 21, 30, 187
abstract_inverted_index.1,	87, 141
abstract_inverted_index.10	241
abstract_inverted_index.2,	142
abstract_inverted_index.8,	91
abstract_inverted_index.In	243
abstract_inverted_index.MD	80
abstract_inverted_index.We	68
abstract_inverted_index.an	209
abstract_inverted_index.at	75, 221, 231, 235, 240, 251, 259
abstract_inverted_index.in	46, 64, 225, 271, 292
abstract_inverted_index.is	41
abstract_inverted_index.of	36, 49, 78, 172, 178, 190, 204, 218
abstract_inverted_index.on	25
abstract_inverted_index.or	58
abstract_inverted_index.to	32, 42, 56, 89, 257, 269
abstract_inverted_index.AUC	213
abstract_inverted_index.Key	154
abstract_inverted_index.May	90
abstract_inverted_index.The	39, 212
abstract_inverted_index.and	17, 105, 126, 143, 164, 176, 201, 238, 253, 282, 290, 294
abstract_inverted_index.for	8, 103, 156, 215
abstract_inverted_index.our	133
abstract_inverted_index.the	34, 47, 65, 76, 94, 111, 202, 216, 226, 244, 247, 260
abstract_inverted_index.use	171, 177, 203
abstract_inverted_index.was	206
abstract_inverted_index.way	31
abstract_inverted_index.0.70	258
abstract_inverted_index.0.77	239
abstract_inverted_index.0.80	234
abstract_inverted_index.0.81	230, 250
abstract_inverted_index.AUCs	248
abstract_inverted_index.ESBC	71
abstract_inverted_index.HER2	124
abstract_inverted_index.This	264
abstract_inverted_index.age,	118, 161
abstract_inverted_index.care	274
abstract_inverted_index.data	102
abstract_inverted_index.high	162
abstract_inverted_index.over	140
abstract_inverted_index.risk	189
abstract_inverted_index.same	112
abstract_inverted_index.test	227
abstract_inverted_index.time	223
abstract_inverted_index.tool	265
abstract_inverted_index.were	184, 229, 249
abstract_inverted_index.will	284
abstract_inverted_index.with	96, 110, 186, 208
abstract_inverted_index.(ROC)	151
abstract_inverted_index.1,644	108
abstract_inverted_index.1997,	88
abstract_inverted_index.2020.	92
abstract_inverted_index.Brain	2
abstract_inverted_index.Jules	98
abstract_inverted_index.Ki-67	195
abstract_inverted_index.Texas	79
abstract_inverted_index.Using	131
abstract_inverted_index.based	24
abstract_inverted_index.brain	37, 60, 137, 157, 191, 219, 277
abstract_inverted_index.cases	72, 109
abstract_inverted_index.delay	59
abstract_inverted_index.early	63
abstract_inverted_index.mark.	262
abstract_inverted_index.model	95, 135
abstract_inverted_index.onset	62
abstract_inverted_index.risk.	211, 279
abstract_inverted_index.size;	170
abstract_inverted_index.their	15
abstract_inverted_index.these	286
abstract_inverted_index.tools	44
abstract_inverted_index.trial	54
abstract_inverted_index.tumor	27, 119, 169
abstract_inverted_index.(ESBC)	12
abstract_inverted_index.40,290	70
abstract_inverted_index.Cancer	82
abstract_inverted_index.Higher	193
abstract_inverted_index.I-III)	74
abstract_inverted_index.aiding	45
abstract_inverted_index.breast	10
abstract_inverted_index.cancer	11
abstract_inverted_index.cohort	228
abstract_inverted_index.create	43
abstract_inverted_index.grade,	194
abstract_inverted_index.higher	168
abstract_inverted_index.models	115
abstract_inverted_index.offers	29, 266
abstract_inverted_index.these,	132
abstract_inverted_index.values	214
abstract_inverted_index.years,	145, 233, 237, 255
abstract_inverted_index.years.	242
abstract_inverted_index.(grade,	121
abstract_inverted_index.(stages	73
abstract_inverted_index.10-year	261
abstract_inverted_index.Bordet,	99
abstract_inverted_index.Center,	83
abstract_inverted_index.January	86
abstract_inverted_index.METHODS	67
abstract_inverted_index.RESULTS	153
abstract_inverted_index.cohort,	246
abstract_inverted_index.cohorts	55
abstract_inverted_index.concern	7
abstract_inverted_index.enhance	285
abstract_inverted_index.hormone	122
abstract_inverted_index.levels,	196
abstract_inverted_index.models,	287
abstract_inverted_index.overall	18
abstract_inverted_index.patient	101, 117, 273
abstract_inverted_index.prevent	57
abstract_inverted_index.primary	26
abstract_inverted_index.status,	198
abstract_inverted_index.support	268
abstract_inverted_index.therapy	183
abstract_inverted_index.through	147
abstract_inverted_index.various	222
abstract_inverted_index.younger	160
abstract_inverted_index.Abstract	0
abstract_inverted_index.Anderson	81
abstract_inverted_index.Belgium,	100
abstract_inverted_index.Houston,	84
abstract_inverted_index.Institut	97
abstract_inverted_index.Receiver	148
abstract_inverted_index.accuracy	104
abstract_inverted_index.clinical	53, 293
abstract_inverted_index.disease.	66
abstract_inverted_index.estrogen	163, 180
abstract_inverted_index.features	120
abstract_inverted_index.included	159
abstract_inverted_index.invasion	200
abstract_inverted_index.nomogram	23
abstract_inverted_index.presents	4
abstract_inverted_index.receptor	166, 181
abstract_inverted_index.research	283, 295
abstract_inverted_index.reviewed	69
abstract_inverted_index.spanning	85
abstract_inverted_index.status),	125
abstract_inverted_index.survival	16
abstract_inverted_index.therapy,	175
abstract_inverted_index.valuable	267
abstract_inverted_index.Operating	149
abstract_inverted_index.Validated	93
abstract_inverted_index.analysis.	152
abstract_inverted_index.analyzing	107
abstract_inverted_index.aromatase	173
abstract_inverted_index.decisions	275
abstract_inverted_index.decreased	188
abstract_inverted_index.endocrine	129
abstract_inverted_index.enriching	52
abstract_inverted_index.evaluated	146
abstract_inverted_index.high-risk	50
abstract_inverted_index.impacting	14
abstract_inverted_index.inclusion	113
abstract_inverted_index.increased	210
abstract_inverted_index.inhibitor	174
abstract_inverted_index.intervals	224
abstract_inverted_index.modulator	182
abstract_inverted_index.objective	40
abstract_inverted_index.patients,	13, 51
abstract_inverted_index.predicted	136
abstract_inverted_index.receptor,	123
abstract_inverted_index.regarding	276
abstract_inverted_index.selective	179
abstract_inverted_index.settings.	296
abstract_inverted_index.therapy).	130
abstract_inverted_index.BACKGROUND	1
abstract_inverted_index.Continuous	280
abstract_inverted_index.University	77
abstract_inverted_index.anticipate	33
abstract_inverted_index.associated	185, 207
abstract_inverted_index.bolstering	288
abstract_inverted_index.clinicians	270
abstract_inverted_index.considered	116
abstract_inverted_index.decreasing	256
abstract_inverted_index.likelihood	35
abstract_inverted_index.metastasis	3, 61, 138, 158, 220, 278
abstract_inverted_index.occurrence	139
abstract_inverted_index.prediction	217
abstract_inverted_index.predictive	22
abstract_inverted_index.predictors	155
abstract_inverted_index.treatments	127
abstract_inverted_index.validation	245, 281
abstract_inverted_index.CONCLUSIONS	263
abstract_inverted_index.early-stage	9
abstract_inverted_index.metastasis.	38, 192
abstract_inverted_index.percentage,	167
abstract_inverted_index.reliability	289
abstract_inverted_index.significant	6
abstract_inverted_index.well-being.	19
abstract_inverted_index.Constructing	20
abstract_inverted_index.chemotherapy	205
abstract_inverted_index.multivariate	134
abstract_inverted_index.personalized	272
abstract_inverted_index.progesterone	165
abstract_inverted_index.HER2-positive	197
abstract_inverted_index.applicability	291
abstract_inverted_index.(chemotherapy,	128
abstract_inverted_index.Characteristic	150
abstract_inverted_index.identification	48
abstract_inverted_index.lymphovascular	199
abstract_inverted_index.characteristics	28
abstract_inverted_index.reproducibility	106
abstract_inverted_index.criteria.Statistical	114
cited_by_percentile_year
countries_distinct_count	2
institutions_distinct_count	7
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.75
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.15837867
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False